ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae

被引:166
作者
Elefteriou, Florent
Benson, M. Douglas
Sowa, Hideaki
Starbuck, Michael
Liu, Xiuyun
Ron, David
Parada, Luis F.
Karsenty, Gerard
机构
[1] Baylor Coll Med, Bone Dis Program Texas, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA
[3] Vanderbilt Univ, Med Ctr, Dept Med, Vanderbilt Ctr Bone Biol, Nashville, TN 37232 USA
[4] Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA
[5] NYU, Sch Med, Skirball Inst, Dept Med, New York, NY 10016 USA
[6] NYU, Sch Med, Skirball Inst, Dept Cell Biol, New York, NY 10016 USA
[7] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA
关键词
D O I
10.1016/j.cmet.2006.10.010
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The transcription factor ATF4 enhances bone formation by favoring amino acid import and collagen synthesis in osteoblasts, a function requiring its phosphorylation by RSK2, the kinase inactivated in Coffin-Lowry Syndrome. Here, we show that in contrast, RSK2 activity, ATF4-dependent collagen synthesis, and bone formation are increased in mice lacking neurofibromin in osteoblasts (Nf1(ob)(-/-) mice). Independently of RSK2, ATF4 phosphorylation by PKA is enhanced in Nf1(ob)(-/-) mice, thereby increasing Rankl expression, osteoclast differentiation, and bone resorption. In agreement with ATF4 function in amino acid transport, a low-protein diet decreased bone protein synthesis and normalized bone formation and bone mass in Nf1(ob)(-/-) mice without affecting other organ weight, while a high-protein diet overcame Atf4(-/-) and Rsk2(-/-) mice developmental defects, perinatal lethality, and low bone mass. By showing that ATF4-dependent skeletal dysplasiae are treatable by dietary manipulations, this study reveals a molecular connection between nutrition and skeletal development.
引用
收藏
页码:441 / 451
页数:11
相关论文
共 53 条
  • [1] Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)?
    Alwan, S
    Tredwel, SJ
    Friedman, JM
    [J]. CLINICAL GENETICS, 2005, 67 (05) : 378 - 390
  • [2] BASHEY RI, 1989, J LAB CLIN MED, V113, P604
  • [3] Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization
    Bi, WM
    Huang, WD
    Whitworth, DJ
    Deng, JM
    Zhang, ZP
    Behringer, RR
    de Crombrugghe, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) : 6698 - 6703
  • [4] A twist code determines the onset of osteoblast differentiation
    Bialek, P
    Kern, B
    Yang, XL
    Schrock, M
    Sosic, D
    Hong, N
    Wu, H
    Yu, K
    Ornitz, DM
    Olson, EN
    Justice, MJ
    Karsenty, G
    [J]. DEVELOPMENTAL CELL, 2004, 6 (03) : 423 - 435
  • [5] Mouse α1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast
    Dacquin, R
    Starbuck, M
    Schinke, T
    Karsenty, G
    [J]. DEVELOPMENTAL DYNAMICS, 2002, 224 (02) : 245 - 251
  • [6] Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK
    Dalby, KN
    Morrice, N
    Caudwell, FB
    Avruch, J
    Cohen, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) : 1496 - 1505
  • [7] Neurofibromatosis 1: closing the GAP between mice and men
    Dasgupta, B
    Gutmann, DH
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2003, 13 (01) : 20 - 27
  • [8] Uncharged tRNA activates GCN2 by displacing the protein kinase moiety from a bipartite tRNA-Binding domain
    Dong, JS
    Qiu, HF
    Garcia-Barrio, M
    Anderson, J
    Hinnebusch, AG
    [J]. MOLECULAR CELL, 2000, 6 (02) : 269 - 279
  • [9] Increased bone formation in osteocalcin-deficient mice
    Ducy, P
    Desbois, C
    Boyce, B
    Pinero, G
    Story, B
    Dunstan, C
    Smith, E
    Bonadio, J
    Goldstein, S
    Gundberg, C
    Bradley, A
    Karsenty, G
    [J]. NATURE, 1996, 382 (6590) : 448 - 452
  • [10] Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass
    Ducy, P
    Amling, M
    Takeda, S
    Priemel, M
    Schilling, AF
    Beil, FT
    Shen, JH
    Vinson, C
    Rueger, JM
    Karsenty, G
    [J]. CELL, 2000, 100 (02) : 197 - 207